October 01, 2014 2:31 AM ET


Company Overview of Ikano Therapeutics Inc.

Company Overview

As of November 22, 2010, Ikano Therapeutics Inc. went out of business. Ikano Therapeutics Inc., a specialty pharmaceutical company, focuses on developing nasal spray drug products to treat pain and central nervous system disorders. It develops hydro morphone, which is used to treat acute and moderate-to-severe pain; and midazolam that is used for the treatment of epileptic seizures. Ikano Therapeutics Inc. was formerly known as Intranasal Therapeutics, Inc. The company was founded in 1998 and is based in Montvale, New Jersey.

210 Summit Avenue

Suite A-13

Montvale, NJ 07645

United States

Founded in 1998





Key Executives for Ikano Therapeutics Inc.

Ikano Therapeutics Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Nostrum Laboratories, Inc. United States
Stonebridge Pharma LLC United States
Forest Pharmaceuticals, Inc. United States
Unimed Pharmaceuticals, LLC United States
Candeoo, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ikano Therapeutics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.